Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D04FYU
|
|||
| Former ID |
DIB005005
|
|||
| Drug Name |
DMP-444
|
|||
| Indication | Coronary artery disease [ICD-11: BA80; ICD-10: I25.1, I25.4] | Phase 3 | [1] | |
| Company |
Bristol-Myers Squibb Pharma Co
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Evaluation of 99mTc-labeled cyclic RGD peptide with a PEG4 linker for thrombosis imaging: comparison with DMP444. Bioconjug Chem. 2011 Aug 17;22(8):1715-22. | |||
| REF 2 | Evaluation of Tc-99m-labeled glycoprotein IIb/IIIa receptor antagonist DMP444 SPECT in patients with infective endocarditis. Clin Nucl Med. 2003 Jun;28(6):480-4. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.